Table 1.
Subsets | Sites | Transcriptional factors | Phenotypic markers | TLR expressions | Functions |
---|---|---|---|---|---|
cDC | Lymphoid organ | Irf4, Rbpj, Batf3, Irf8 | CD11b, CD11c, CD172a, CD103, CD8α, XCR1, Clec9a | TLR1, 2, 3, 4, 6, 7, 8, 9 | Antigen presentation, induction of antitumor responses, induction of Th2 T cell responses, migration, antigen cross presentation |
pDC | Most organs | Tcf-4 | CD11c, B220, Ly6C, Siglec-H | TLR1, 2, 4, 5, 6, 7, 8, 9 | Antigen presentation, type I IFN production, tumor killing |
moDC | Most organs | Unknown | CD11b, F4/80, Ly6c, CD206, CD64, MHC II, Mac-3/CD107b FcεRI, CD115/GM-CSFR | TLR2, 3, 4, 7, 9 | Antigen presentation, induction of antitumor responses, migration, production of TNF and NO, tumor rejection |
LC | Skin | PU.1, ID2, Irf4, Irf8 | CD36, CD1a, CD1c, CD207, HLA-DR, CD86 | TLR1,3,6,7 | Antigen presentation, radioresistance, adaptive immunity |
cDC: classical DC; Irf4: interferon regulatory factor 4; Rbpj: recombination signal binding protein-J; Batf3: basic leucine zipper transcriptional factor ATF-like 3; IFN: interferon; Irf8: IFN regulatory factor 8; CD: cluster of differentiation; XCR1: X-C motif chemokine receptor 1; Clec9a: C-type lectin domain family 9, member A; TLR: Toll-like receptor; Th2: T helper type 2; pDC: plasmacytoid DC; Tcf-4: transcription factor 4; Siglec-H: sialic acid-binding immunoglobulin-like lectin-h; moDC: monocyte-derived DC; MHC II: major histocompatibility complex class II; FcεRI: high-affinity immunoglobulin E receptor; GM-CSFR: granulocyte-macrophage colony-stimulating factor receptor; TNF: tumor necrosis factor; NO: nitric oxide; LC: Langerhans cell; ID2: inhibitor of DNA binding 2; HLA-DR: human leukocyte antigen DR.